Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate
(21)
- Information Technology Services Directorate (2)
- National Security Sciences Directorate
(17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
- (-) Isotope Science and Enrichment Directorate (6)
Researcher
- Mike Zach
- Andrew F May
- Ben Garrison
- Brad Johnson
- Bruce Moyer
- Charlie Cook
- Christopher Hershey
- Christopher Hobbs
- Craig Blue
- Daniel Rasmussen
- Debjani Pal
- Eddie Lopez Honorato
- Hsin Wang
- James Klett
- Jeffrey Einkauf
- Jennifer M Pyles
- John Lindahl
- Justin Griswold
- Kuntal De
- Laetitia H Delmau
- Louise G Evans
- Luke Sadergaski
- Matt Kurley III
- Nedim Cinbiz
- Padhraic L Mulligan
- Richard L. Reed
- Rodney D Hunt
- Ryan Heldt
- Sandra Davern
- Tony Beard
- Tyler Gerczak

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

Sintering additives to improve densification and microstructure control of UN provides a facile approach to producing high quality nuclear fuels.

The technologies provide a system and method of needling of veiled AS4 fabric tape.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

ORNL will develop an advanced high-performing RTG using a novel radioisotope heat source.

The use of Fluidized Bed Chemical Vapor Deposition to coat particles or fibers is inherently slow and capital intensive, as it requires constant modifications to the equipment to account for changes in the characteristics of the substrates to be coated.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence